Shares of Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) traded up 2.4% on Wednesday . The stock traded as high as €60.10 ($68.30) and last traded at €59.70 ($67.84). 149,308 shares changed hands during trading, an increase of 58% from the average session volume of 94,405 shares. The stock had previously closed at €58.30 ($66.25).
Carl Zeiss Meditec Stock Down 2.2%
The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41. The firm has a 50 day moving average of €58.60 and a two-hundred day moving average of €56.16. The firm has a market capitalization of $5.30 billion, a price-to-earnings ratio of 30.41, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98.
About Carl Zeiss Meditec
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Read More
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
